Argen-X (ARGX) - Total Liabilities

Latest as of June 2026: €1.61 Billion EUR ≈ $1.89 Billion USD

Based on the latest financial reports, Argen-X (ARGX) has total liabilities worth €1.61 Billion EUR (≈ $1.89 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Argen-X - Total Liabilities Trend (2010–2025)

This chart illustrates how Argen-X's total liabilities have evolved over time, based on quarterly financial data. Explore ARGX long-term investments to assets to see how much of total assets are deployed in long-term investments.

Argen-X Competitors by Total Liabilities

The table below lists competitors of Argen-X ranked by their total liabilities.

Company	Country	Total Liabilities
Ventas Inc NYSE:VTR	USA	$14.44 Billion
Xcel Energy Inc NASDAQ:XEL	USA	$63.11 Billion
E.ON SE F:EOAN	Germany	€84.85 Billion
E.ON SE F:EOAA	Germany	€84.85 Billion
Shengyi Technology Co Ltd SHG:600183	China	CN¥15.94 Billion
DnB ASA OL:DNB	Norway	Nkr3.60 Trillion
Thomson Reuters Corp TO:TRI	Canada	CA$6.02 Billion
Erste Group Bank AG VI:EBS	Austria	€419.45 Billion

Liability Composition Analysis (2010–2025)

This chart breaks down Argen-X's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ARGX total assets.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.12	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Argen-X's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Argen-X (2010–2025)

The table below shows the annual total liabilities of Argen-X from 2010 to 2025.

Year	Total Liabilities	Change
2025-12-31	€1.36 Billion ≈ $1.59 Billion	+93.08%
2024-12-31	€704.24 Million ≈ $823.33 Million	+58.27%
2023-12-31	€444.95 Million ≈ $520.19 Million	+38.80%
2022-12-31	€320.56 Million ≈ $374.77 Million	+1.43%
2021-12-31	€316.05 Million ≈ $369.50 Million	-47.79%
2020-12-31	€605.36 Million ≈ $707.72 Million	+40.84%
2019-12-31	€429.81 Million ≈ $502.49 Million	+837.86%
2018-12-31	€45.83 Million ≈ $53.58 Million	+47.05%
2017-12-31	€31.16 Million ≈ $36.43 Million	-30.11%
2016-12-31	€44.59 Million ≈ $52.13 Million	+369.65%
2015-12-31	€9.49 Million ≈ $11.10 Million	-7.36%
2014-12-31	€10.25 Million ≈ $11.98 Million	+124.36%
2013-12-31	€4.57 Million ≈ $5.34 Million	-27.24%
2012-12-31	€6.28 Million ≈ $7.34 Million	+55.30%
2011-12-31	€4.04 Million ≈ $4.73 Million	+99.25%
2010-12-31	€2.03 Million ≈ $2.37 Million	--

About Argen-X

BR:ARGX Belgium Biotechnology

Market Cap

$65.58 Billion

€56.09 Billion EUR

Market Cap Rank

#578 Global

#2 in Belgium

Share Price

€902.00

Change (1 day)

+1.90%

52-Week Range

€583.20 - €902.00

All Time High

€902.00